|
Poulvac AE
|
-
|
V/MRP/08/1572
|
Zoetis Belgium S.A., Beļģija
|
QI01AD02
|
chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/08/1572-01 |
|
1 |
Flakons, 1000 deva |
-
|
| V/MRP/08/1572-02 |
|
10 |
Flakons, 1000 deva |
-
|
| V/MRP/08/1572-03 |
|
1 |
Flakons, 2000 deva |
-
|
| V/MRP/08/1572-04 |
|
10 |
Flakons, 2000 deva |
-
|
|
|
Engemycin
|
100 mg/ml
|
V/NRP/93/0029
|
Intervet International B.V., Nīderlande
|
QJ01AA06
|
cattle; pigs; sheep; horses; dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/93/0029-01 |
100 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
| V/NRP/93/0029-02 |
100 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
| V/NRP/93/0029-03 |
100 mg/ml |
1 |
PET flakons, 100 ml |
-
|
| V/NRP/93/0029-04 |
100 mg/ml |
1 |
PET flakons, 250 ml |
-
|
|
|
Linco-Spectin 100
|
-
|
V/MRP/93/0152
|
PHIBRO ANIMAL HEALTH (POLAND) Sp. z o.o., Polija
|
QJ01FF52
|
pigs; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/93/0152-01 |
|
1 |
Plastikāta konteiners, 150 g |
-
|
| V/MRP/93/0152-02 |
|
1 |
Plastikāta konteiners, 1500 g |
-
|
|
|
Halofusol
|
0.5 mg/ml
|
V/DCP/20/0029
|
LABORATORIOS KARIZOO, S.A., Spānija
|
QP51AX08
|
calves
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/20/0029-01 |
0,5 mg/ml |
1 |
ABPE pudele, 250 ml |
-
|
| V/DCP/20/0029-02 |
0,5 mg/ml |
1 |
ABPE pudele, 500 ml |
-
|
| V/DCP/20/0029-03 |
0,5 mg/ml |
1 |
ABPE pudele, 1000 ml |
-
|
| V/DCP/20/0029-04 |
0,5 mg/ml |
1 |
ABPE pudele ar dozēšanas sūkni, 250 ml |
-
|
| V/DCP/20/0029-05 |
0,5 mg/ml |
1 |
ABPE pudele ar dozēšanas sūkni, 500 ml |
-
|
| V/DCP/20/0029-06 |
0,5 mg/ml |
1 |
ABPE pudele ar dozēšanas sūkni, 1000 ml |
-
|
| V/DCP/20/0029-07 |
0,5 mg/ml |
1 |
ABPE pudele, 250 ml |
-
|
| V/DCP/20/0029-08 |
0,5 mg/ml |
1 |
ABPE pudele, 500 ml |
-
|
| V/DCP/20/0029-09 |
0,5 mg/ml |
1 |
ABPE pudele, 1000 ml |
-
|
|
|
Nobivac Rabies
|
-
|
V/NRP/93/0040
|
Intervet International B.V., Nīderlande
|
QI07AA02
|
ferrets; cattle; sheep; goats; horses; dogs; cats; foxes
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/93/0040-01 |
|
10 |
Flakons, 1 deva |
-
|
| V/NRP/93/0040-02 |
|
10 |
Flakons, 10 deva |
-
|
|
|
IVERTOTAL
|
10 mg/ml
|
V/SRP/26/0028
|
S P Veterinaria S.A., Spānija
|
QP54AA01
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/SRP/26/0028-01 |
|
1 |
Flakons, 250 ml |
-
|
| V/SRP/26/0028-02 |
|
1 |
Flakons, 500 ml |
-
|
| V/SRP/26/0028-03 |
|
10 |
Flakons, 250 ml |
-
|
| V/SRP/26/0028-04 |
|
10 |
Flakons, 500 ml |
-
|
|
|
Masti Veyxym
|
-
|
V/NRP/00/1078
|
Veyx-Pharma GmbH, Vācija
|
QD03BA
|
cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/00/1078-01 |
|
10 |
Injektors, 10 g |
-
|
|
|
Syvazul BTV
|
-
|
EU/2/18/231/011
|
Laboratorios SYVA S.A.U, Spānija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bluetongue virus, serotype 4, strain SPA-1/2004, Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
LABORATORIOS SYVA, S.A.U. , Spānija
|
| Date of authorisation/renewal: |
09-Jan-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/231/011 |
|
1 |
Polipropilēna flakons, 80 ml |
-
|
|
|
Profender spot-on solution for large cats
|
-
|
EU/2/05/054/015
|
Vetoquinol S.A., Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Praziquantel,Emodepside
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
27-Jul-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/054/015 |
|
20 |
Pipete, 1 deva |
-
|
|
|
Syvazul BTV
|
-
|
EU/2/18/231/006
|
Laboratorios SYVA S.A.U, Spānija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
LABORATORIOS SYVA, S.A.U. , Spānija
|
| Date of authorisation/renewal: |
09-Jan-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/231/006 |
|
1 |
Polipropilēna flakons, 200 ml |
-
|
|
|
Mexxam Vet
|
0.25 mg
|
V/DCP/22/0055
|
Alfasan Nederland BV, Nīderlande
|
QM01AC06
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
19-Dec-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
-
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
[DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0055-01 |
0,25 mg |
1 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/22/0055-02 |
0,25 mg |
3 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/22/0055-03 |
0,25 mg |
6 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/22/0055-04 |
0,25 mg |
9 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
| V/DCP/22/0055-05 |
0,25 mg |
12 |
OPA/Al/PVH-Al blisteris, 10 tablete |
-
|
|
|
DIVENCE IBR MARKER LIVE
|
-
|
EU/2/24/318/003
|
Laboratorios Hipra S.A., Spānija
|
QI02AD01
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Bovine herpesvirus 1, strain CEDDEL, gE- tk- double-gene deleted, Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
09-Aug-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/318/003 |
|
1 |
I tipa stikla flakons, 40 deva |
-
|
|
|
Profender tablets for medium dogs
|
-
|
EU/2/05/054/027
|
Vetoquinol S.A., Francija
|
QP52AA51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
modified-release tablets
|
| International name (active substance): |
Praziquantel,Emodepside
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
29-Jul-2010
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/054/027 |
50 mg/10 mg |
102 |
Alumīnija blisteris, 1 tablete |
-
|
|
|
UpCard
|
0.75 mg
|
EU/2/15/184/001
|
Vetoquinol S.A., Francija
|
QC03CA04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Torasemide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
24-Jun-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/184/001 |
0,75 mg |
3 |
PVH/PHTFE alumīnija blisteris, 10 tablete |
-
|
|
|
AviGate S. Infantis
|
-
|
EU/2/26/364/001
|
Huvepharma NV, Beļģija
|
QI01AE01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for use in drinking water
|
| International name (active substance): |
Salmonella enterica, subsp. enterica, serovar Infantis, strain J-6-24 cpxRA- lon1-, live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
27-Apr-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/364/001 |
|
10 |
I tipa stikla flakons, 20 ml/1000 deva |
-
|
|
|
Enzaprost
|
5 mg/ml
|
V/I/26/0025
|
Ceva Santé Animale, Beļģija
|
QG02AD01
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Dinoproston tromethamine
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale,, Francija
|
| Date of authorisation/renewal: |
19-May-2026
|
| Marketing authorisation valid until: |
18-May-2031
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOC] 19052026LI (19-May-2026)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/26/0025-01 |
|
1 |
Stikla flakons (caurspīdīgs), 50 ml |
[PDF]
|
|
|
Lotilaner/Milbemycin Elanco 225 mg/8,44 mg
|
-
|
EU/2/26/361/010
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
25-Feb-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/361/010 |
|
3 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Porcilis AR - T DF
|
-
|
EU/2/00/026/005
|
Intervet International Booxmer, Nīderlande
|
QI09AB04
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated Bordetella bronchiseptica, Pasteurella multocida toxoid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
08-Feb-2006
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/00/026/005 |
|
1 |
PET pudele, 50 deva |
-
|
|
|
Previcox
|
227 mg
|
EU/2/04/045/004
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
29-May-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/045/004 |
227 mg |
3 |
PVH/Al blisteris, 10 tablete |
-
|
|
|
Advocate Spot-on lieliem kaķiem
|
-
|
EU/2/03/039/035
|
Bayer Animal Health , Vācija
|
QP54AB52
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
16-Jul-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/035 |
|
1 |
Pipete, 0,8 ml |
-
|
|